e-learning
resources
London 2016
Tuesday, 06.09.2016
Future challenges in pulmonary arterial hypertension: An ERS/ESC, and Patient Organisation PAH Europe joint symposium
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The clinical perspective
Anton Vonk Noordegraaf (Amsterdam, Netherlands)
Source:
International Congress 2016 – Future challenges in pulmonary arterial hypertension: An ERS/ESC, and Patient Organisation PAH Europe joint symposium
Session:
Future challenges in pulmonary arterial hypertension: An ERS/ESC, and Patient Organisation PAH Europe joint symposium
Session type:
Symposium
Number:
4511
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Anton Vonk Noordegraaf (Amsterdam, Netherlands). The clinical perspective. International Congress 2016 – Future challenges in pulmonary arterial hypertension: An ERS/ESC, and Patient Organisation PAH Europe joint symposium
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Patient perspective of participation in COVID-19 clinical trials
Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases
Year: 2021
The patient perspective
Source: International Congress 2017 – Primary Care programme 2017 (part II)
Year: 2017
The impact of hands-on respiratory management for physicians in clinical practice and its future perspective
Source: Annual Congress 2012 - Improving education for the healthcare team and patients
Year: 2012
A paediatric perspective
Source: Eur Respir Monogr 2014; 66: 84-97
Year: 2014
Pirfenidone: an update on clinical trial data and insights from everyday practice
Source: Eur Respir Rev 2014; 23: 111-117
Year: 2014
The disease model: implications for clinical practice
Source: Eur Respir J, 51 (4) 1800188; 10.1183/13993003.00188-2018
Year: 2018
Clinical trial landscape for M/XDR-TB: current evidence and future perspectives
Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Year: 2019
Models of translating clinical research into practice
Source: Annual Congress 2008 - MP6 - Role of allied respiratory professionals in clinical research
Year: 2008
A toxicological perspective
Source: ERS Research Seminar 2017 – The impact of air pollution on respiratory health
Year: 2018
Starting clinical research in a limited resource environment
Source: International Congress 2014 – ME06 Starting clinical research in a limited resource environment
Year: 2014
COVID-19 and COPD: a narrative review of the basic science and clinical outcomes
Source: Eur Respir Rev, 29 (158) 200199; 10.1183/16000617.0199-2020
Year: 2020
Opportunities and outstanding challenges for integration in clinical practice
Source: Virtual Congress 2021 – Inhale the future: ambulatory sensing technologies, digital biomarkers and explainable insights
Year: 2021
What requirements should a biomarker meet to be used in the clinical and epidemiological setting?
Source: Annual Congress 2008 - Biomarkers in COPD - application in clinical and epidemiological studies
Year: 2008
Distinct clinical phenotypes of airways disease: a primary-care clinician perspective
Source: Eur Respir J 2010; 35: 459
Year: 2010
Lightning lecture: Clinical and scientific work from a clinical perspective
Source: International Congress 2016 – PD9 Combining the clinic and research
Year: 2016
Lung function trajectory research: historical perspective and future prospects
Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today
Year: 2021
From clinical trials to real-world data: New dimensions of patient benefits
Source: International Congress 2015 – IgE-mediated asthma: New revelations and future insights
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept